A microRNA signature for risk-stratification and response prediction to FOLFOX-based adjuvant therapy in stage II and III colorectal cancer.

ABSTRACT:

SUBMITTER: Okuno K 

PROVIDER: S-EPMC9854096 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature